STAASTAAR Surgical Company

$871M

Q3 2019 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$39M+22.9% YoY

Gross Profit

$29M74.4% margin

Operating Income

$3M8.5% margin

Net Income

$2M6.1% margin

EPS (Diluted)

$0.05

QoQ Revenue Growth

-1.5%

Cash Flow

Operating Cash Flow

$12M

Free Cash Flow

$9M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$193M

Total Liabilities

$43M

Stockholders' Equity

$149M

Cash & Equivalents

$112M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$39M	$32M	+22.9%
Gross Profit	$29M	$24M	+21.8%
Operating Income	$3M	$2M	+110.6%
Net Income	$2M	$1M	+63.7%

Revenue Segments

Implantable Collamer Lenses

$34M87%

Intraocular Lenses

$4M10%

Other Surgical Products

$1M3%

Geographic Segments

CHINA

$18M47%

Other Countries

$13M34%

JAPAN

$7M19%

STAA Q3 2019 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena